TickerFacts.

Interpace Biosciences, Inc. (IDXG): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$22.36M
As of 2025-12-31
$23.24M
As of 2026-06-30
$69.51M2010-12-31: $69.51M2011-12-31: $59.52M2012-12-31: $35.63M2013-12-31: $32.48M2014-09-30: $25.31M2014-12-31: $19.43M2015-03-31: $15.18M2015-06-30: $8.35M2015-09-30: $3.40M2015-12-31: $10.07M2016-03-31: $4.83M2016-06-30: $2.00M2016-09-30: -$5.98M2016-12-31: -$10.11M2017-03-31: $7.84M2017-06-30: $19.53M2017-09-30: $19.48M2017-12-31: $22.89M2018-03-31: $22.70M2018-06-30: $21.41M2018-09-30: $18.80M2018-12-31: $15.45M2019-03-31: $18.37M2019-06-30: $13.35M2019-09-30: $6.03M2019-12-31: -$4.48M2020-03-31: -$10.90M2020-06-30: -$16.13M2020-09-30: -$21.80M2020-12-31: -$29.08M2021-12-31: -$42.42M2022-12-31: -$63.07M2023-03-31: -$57.39M2023-06-30: -$56.68M2023-09-30: -$56.72M2023-12-31: -$55.54M2024-03-31: -$54.77M2024-06-30: -$52.28M2024-09-30: -$50.54M2024-12-31: -$2.22M2025-12-31: $22.36M$22.36M
2010-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$22.36Mn/m2026-03-30, Balance as of period end
2024-12-31-$2.22Mn/a2026-03-30, Balance as of period end
2024-09-30-$50.54Mn/a2025-03-31, Balance as of period end
2024-06-30-$52.28Mn/a2025-03-31, Balance as of period end
2024-03-31-$54.77Mn/a2025-03-31, Balance as of period end
2023-12-31-$55.54Mn/a2025-03-31, Balance as of period end
2023-09-30-$56.72Mn/a2025-03-31, Balance as of period end
2023-06-30-$56.68Mn/a2025-03-31, Balance as of period end
2023-03-31-$57.39Mn/c2025-03-31, Balance as of period end
2022-12-31-$63.07Mn/m2024-04-01, Balance as of period end
2021-12-31-$42.42Mn/m2023-03-27, Balance as of period end
2020-12-31-$29.08Mn/a2022-03-31, Balance as of period end
2020-09-30-$21.80Mn/a2021-04-01, Balance as of period end
2020-06-30-$16.13Mn/a2021-04-01, Balance as of period end
2020-03-31-$10.90Mn/a2021-04-01, Balance as of period end
2019-12-31-$4.48Mn/a2021-04-01, Balance as of period end
2019-09-30$6.03Mn/a2021-04-01, Balance as of period end
2019-06-30$13.35Mn/a2021-04-01, Balance as of period end
2019-03-31$18.37Mn/a2021-04-01, Balance as of period end
2018-12-31$15.45Mn/a2021-01-19, Balance as of period end
2018-09-30$18.80Mn/a2021-01-19, Balance as of period end
2018-06-30$21.41Mn/a2021-01-19, Balance as of period end
2018-03-31$22.70Mn/a2021-01-19, Balance as of period end
2017-12-31$22.89Mn/a2021-01-19, Balance as of period end
2017-09-30$19.48Mn/a2021-01-19, Balance as of period end
2017-06-30$19.53Mn/a2021-01-19, Balance as of period end
2017-03-31$7.84Mn/a2021-01-19, Balance as of period end
2016-12-31-$10.11Mn/a2021-01-19, Balance as of period end
2016-09-30-$5.98Mn/a2021-01-19, Balance as of period end
2016-06-30$2.00Mn/a2021-01-19, Balance as of period end
2016-03-31$4.83Mn/a2021-01-19, Balance as of period end
2015-12-31$10.07Mn/a2021-01-19, Balance as of period end
2015-09-30$3.40Mn/a2021-01-19, Balance as of period end
2015-06-30$8.35Mn/a2021-01-19, Balance as of period end
2015-03-31$15.18Mn/a2021-01-19, Balance as of period end
2014-12-31$19.43Mn/a2021-01-19, Balance as of period end
2014-09-30$25.31Mn/a2021-01-19, Balance as of period end
2013-12-31$32.48M-8.8%2015-03-05, Balance as of period end
2012-12-31$35.63M-40.1%2014-03-06, Balance as of period end
2011-12-31$59.52M-14.4%2013-03-15, Balance as of period end
2010-12-31$69.51Mn/a2012-03-09, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Interpace Biosciences, Inc. (IDXG)2025-12-31$22.36Mn/m
Utah Medical Products Inc (UTMD)2025-12-31$119.27M+1.6%
Retractable Technologies Inc (RVP)2025-12-31$74.38M-14.7%
Cytosorbents Corp (CTSO)2025-12-31$5.90M-46.9%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$28.02M+10.4%
KORU Medical Systems, Inc. (KRMD)2025-12-31$17.05M+1.4%
SS Innovations International, Inc. (SSII)2025-12-31$38.22M+184.0%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.62Mn/a
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$53.57M+62.5%

Compare IDXG, UTMD, RVP, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗